These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4271841)
1. Nicotinic acid in the treatment of schizophrenia. Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841 [No Abstract] [Full Text] [Related]
2. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review. Wittkopp TA; Abuzzahab FS Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727 [No Abstract] [Full Text] [Related]
3. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study. Deutsch M; Ananth JV; Ban TA Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260 [No Abstract] [Full Text] [Related]
4. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study. Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601 [No Abstract] [Full Text] [Related]
5. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia. Vallely JF; Lovegrove TD; Hobbs GE Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335 [No Abstract] [Full Text] [Related]
6. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study. Hoffer A Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426 [No Abstract] [Full Text] [Related]
7. Biochemistry of nicotinic acid and nicotinamide. Hoffer A Psychosomatics; 1967; 8(2):95-100. PubMed ID: 4227744 [No Abstract] [Full Text] [Related]
8. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Ananth JV; Ban TA; Lehmann HE Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710 [No Abstract] [Full Text] [Related]
9. A chemical treatment for schizophrenia. Alvarez WC Geriatrics; 1967 Mar; 22(3):111-2. PubMed ID: 4225316 [No Abstract] [Full Text] [Related]
10. Nicotinic acid in the treatment of hypercholesterolemia. A long term study. Charman RC; Matthews LB; Braeuler C Angiology; 1972 Jan; 23(1):29-35. PubMed ID: 5009984 [No Abstract] [Full Text] [Related]
12. Negative findings with nicotinic acid in the treatment of schizophrenias. Ban TA Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570 [No Abstract] [Full Text] [Related]
14. Niacin and the schizophrenic patient. Newbold HL; Mosher LR Am J Psychiatry; 1970 Oct; 127(4):535-6. PubMed ID: 4248216 [No Abstract] [Full Text] [Related]
15. Use of nicotinic acid and/or nicotinamide in high doses to treat schizophrenia. Hoffer A Can J Psychiatr Nurs; 1966 Oct; 7(8):5-6. PubMed ID: 4224196 [No Abstract] [Full Text] [Related]
17. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II. Ban TA; Lehmann HE Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217 [No Abstract] [Full Text] [Related]
18. Letter: NAD and chronic schizophrenia. Altus MS Am J Psychiatry; 1974 Sep; 131(9):1043-4. PubMed ID: 4370155 [No Abstract] [Full Text] [Related]
19. On-going national collaborative studies in Canada: niacin in the treatment of schizophrenias. Ban TA Psychopharmacol Bull; 1969 Jul; 5(3):5-20. PubMed ID: 4906584 [No Abstract] [Full Text] [Related]
20. Megavitamin B-3 therapy for schizophrenia. Hoffer A Can Psychiatr Assoc J; 1971 Dec; 16(6):499-504. PubMed ID: 4947171 [No Abstract] [Full Text] [Related] [Next] [New Search]